About: Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2011 (uk) article scientifique publié en 2011 (fr) im März 2011 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57578352-3FED39C1-F2D1-4BAE-8F73-3C86B4036826
publication date	2011-03-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57578352-1A9DF316-C919-44F0-B5C4-34B6C90B8B96
language of work or name	English
author name string	wds:Q57578352-163A6880-8E6E-4CD5-B4FE-713EB56F100A wds:Q57578352-22EF0690-D700-4A53-858E-E6CA2711D040 wds:Q57578352-2EC08ED5-3D4B-42E2-87DF-15B3A9067DA0 wds:Q57578352-3F192031-7AA5-4330-9E4D-935677048884 wds:Q57578352-7565F3C7-79D8-40BE-86F7-BB74AB38AE41 wds:Q57578352-9E4C3CD5-4BAA-48A9-B512-4E90EA162C11 wds:Q57578352-B556EB7C-2A5B-4A3F-9FEB-F924B56D155F wds:Q57578352-C049AAC3-CFA1-4B25-AFB4-05DCA59660C2 wds:Q57578352-CB85B399-0CBD-40E8-8028-865C4A4A5798 wds:Q57578352-D77D8984-5AA8-4376-AD89-55CB55BBE62A wds:Q57578352-D8A74415-79F3-49CE-8BBF-FE27988FE341 wds:Q57578352-E4F99F7B-1A7C-4B38-A0A1-ABC3B6D4187D wds:Q57578352-EC4D945B-2932-459E-99C1-3E4A515F1ADA
author name string	C. Chen P. G. Morris S. Patil N. Lin M. Fleisher S. Sugarman R. Steingart C. T. Dang R. Lehman A. Abbruzzi H. L. McArthur M. Dickler S. Come
rdfs:label	Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (en) Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (nl)
skos:prefLabel	Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (en) Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (nl)
name	Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (en) Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (nl)
author	wds:Q57578352-0E61CD5A-E438-45DC-B2DF-A2637DFED76E wds:Q57578352-10DB558A-DDA4-4AA5-8A86-9A3A79D6865F wds:Q57578352-A7194437-7E9A-44EC-B123-F7366E79D8ED wds:Q57578352-F04C2CE4-569E-4BA7-A360-8C8F11C28FA5
author	Eric Winer Clifford A Hudis Larry Norton Beverly Moy
title	wds:Q57578352-C2927C45-4F6B-4DEB-9CC9-359CEE8809B2
title	Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib (en)
page(s)	wds:Q57578352-0FB02581-FD11-45F3-994C-59F089797AC0
page(s)	3490-3499
instance of	wds:Q57578352-63BDDFA8-5454-480D-9507-D4ECCEEC5E0E
instance of	scholarly article
main subject	wds:Q57578352-2BE8509A-4F88-4A5B-B833-DC86BDA3C1DF wds:Q57578352-533111C1-FD7B-4BCB-AF21-F70C4AD9B8C0 wds:Q57578352-6A3786C4-7AE7-4A6F-B223-E127D2ABE103 wds:Q57578352-FA62ACF1-2D8B-44B8-AB9A-F476D8BBB263
main subject	trastuzumab breast cancer chemotherapy Patients
PubMed ID	wds:Q57578352-81339762-8971-4D10-AC1A-AE8170884236
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21372222
PubMed ID	21372222
published in	wds:Q57578352-86B4662D-A2B9-4BB2-A71F-60FB9B4BDB60
published in	Clinical Cancer Research
issue	wds:Q57578352-306D6C3B-950F-4232-890A-238022FC9889
volume	wds:Q57578352-55B81B54-BB8C-4056-8C04-F44D6DB655AF
issue	10
volume	17
DOI	wds:Q57578352-2ABAFCB3-EFEB-4BCC-AF32-9C0B1883359D
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-10-1359
DOI	10.1158/1078-0432.CCR-10-1359
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57578352
is cites work of	Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Using cardiac biomarkers and treating cardiotoxicity in cancer Cardiac toxicity of anticancer agents Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer An update on cardio-oncology Cardiovascular prevention in the cancer survivor Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy The role of anthracyclines in the treatment of early breast cancer Identifying cancer patients at risk for cardiotoxicity High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management Current and emerging modalities for detection of cardiotoxicity in cardio-oncology Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software